Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Tissue Antigens ; 74(1): 73-80, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19522772

RESUMEN

Killer immunoglobulin-like receptors (KIRs) expressed on natural killer cells are critical components of innate immunity. Interactions between KIRs and their human leukocyte antigen (HLA) ligands have been shown to influence autoimmune and infectious disease course in defined populations. However, the low throughput and high cost of current methods impede confirmation of the universality of these findings. To support large epidemiology surveys, we developed a high-throughput real-time polymerase chain reaction-based assay to identify carriers of KIR3DL1, KIR3DS1, KIR2DL2, and KIR2DL3 and their HLA ligands. The platform performed with 100% sensitivity and specificity in detection of carrier and non-carrier on reference samples. The application of this platform will further clarify the nature and impact of the KIR-HLA epistatic interaction on disease course in large global population-based studies.


Asunto(s)
Antígenos de Histocompatibilidad Clase I/genética , Reacción en Cadena de la Polimerasa/métodos , Receptores KIR2DL2/genética , Receptores KIR2DL3/genética , Receptores KIR3DL1/genética , Receptores KIR3DS1/genética , Alelos , Genotipo , Humanos , Ligandos , Sensibilidad y Especificidad
2.
Tissue Antigens ; 73(3): 262-9, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19254258

RESUMEN

The objective of this study was to characterize the class I human leukocyte antigen (HLA) genetic composition of the Ugandan population to better define its relationship with other African groups. Samples from 175 individuals from Kampala (Uganda) were subjected to class I HLA-A, -B, and -C sequence-based typing. The high concordance between the major alleles and haplotypes found in the current and Kenyan populations and interpopulation genetic distance analysis strongly supported the presence of an East African cluster that contained the current Ugandan population along with Kenyan Luo and Nandi populations. The congruence of major alleles in different populations would permit consideration of East Africa as an integrated setting when designing and evaluating much needed malaria, tuberculosis, and AIDS vaccines.


Asunto(s)
Alelos , Población Negra/genética , Haplotipos/genética , Antígenos de Histocompatibilidad Clase I/genética , Familia de Multigenes/genética , Humanos , Uganda
3.
Drug Alcohol Depend ; 116(1-3): 24-30, 2011 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-21193272

RESUMEN

BACKGROUND: Dual infection with diverse HIV strains can foster the emergence of recombinants. The resulting increase in viral genetic diversity is a major challenge for vaccine development HIV treatment. In this study we aim to investigate the socio demographic factors associated with an increasing level of genetic diversity among HIV strains in a population of drug-users in Northern Thailand. METHODS: From 1999 through 2000, 2231 volunteers were enrolled in the Opiate-Users Research in Chiang Mai, Thailand. HIV subtype analysis was conducted among those HIV-1 seropositive (n=347) using a multi-region hybridization assay. Social and demographic variables were assessed using a structured questionnaire. RESULTS: Overall, 336/347 (96.8%) of the samples could be typed. 81.8% were CRF01_AE, 3.9% were subtype B, 9.2% were recombinants (mostly between CRF01_AE and B) and 5.1% were dual infections. Dual infections were more frequent among those with a lower education level (AOR: 5.2; 95% CI 1.4-20.3), those who have initiated injecting in the last 3 years (AOR: 3.9; 95% CI 1.1-14.6), and those reporting frequent needle sharing in the last 3 months (AOR: 7.0; 95% CI 1.5-34.1). Both recombinant strains and dual infection were more frequent among those reporting frequent needle sharing in the last 3 months (AOR: 5.3; 95% CI 1.6-17.1). CONCLUSION: To limit the expanding complexity of HIV-1 strains, early intervention should be aimed at reduction in needle sharing, especially among new intravenous drug users.


Asunto(s)
Infecciones por VIH/genética , Seropositividad para VIH/complicaciones , VIH-1/genética , Abuso de Sustancias por Vía Intravenosa/epidemiología , Adolescente , Adulto , Demografía , Consumidores de Drogas , Femenino , Infecciones por VIH/epidemiología , Infecciones por VIH/inmunología , Infecciones por VIH/transmisión , Seropositividad para VIH/epidemiología , Seropositividad para VIH/genética , Seropositividad para VIH/transmisión , VIH-1/clasificación , VIH-1/inmunología , VIH-1/aislamiento & purificación , Humanos , Masculino , Factores de Riesgo , Factores Socioeconómicos , Abuso de Sustancias por Vía Intravenosa/complicaciones , Abuso de Sustancias por Vía Intravenosa/fisiopatología , Trastornos Relacionados con Sustancias/complicaciones , Trastornos Relacionados con Sustancias/epidemiología , Tailandia/epidemiología , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA